US Patent Issued to SPEROGENIX THERAPEUTICS on Sept. 30 for "Heterocyclic compounds as kinase inhibitor and uses thereof" (Indian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,395, issued on Sept. 30, was assigned to SPEROGENIX THERAPEUTICS Ltd. (Hong Kong).

"Heterocyclic compounds as kinase inhibitor and uses thereof" was invented by Dhananjay Pendharkar (Greater Noida, India), Sreekanth A. Ramachandran (Greater Noida, India), Pradeep S. Jadhavar (Greater Noida, India), Dayanand Panpatil (Noida, India), Uzma Saeed (New Delhi), Vivek Kumar (Delhi, India) and Dipshe Bist (Noida, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to compounds useful in treatment of conditions associated with Checkpoint kinase (CHK), particularly CHK-1 enzymes. Specifically, the present invention d...